The global burden of gynecologic oncology disease as reflected in clinical trials: An analysis of over 2,000 clinical trials

被引：0
|
作者：
Richardson, Michael [1 ]
Turner, Brandon [2 ]
Steinberg, Jecca [3 ]
Magnani, Christopher [4 ]
Weeks, Brannon [5 ]
Thirunavu, Vineeth [6 ]
Zhang, Naixin [6 ]
Holder, Kai [3 ]
Cohen, Joshua [1 ]
Salani, Ritu [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Northwestern Feinberg Sch Med, Chicago, IL USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Mass Gen Brigham, Boston, MA USA
[6] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
427
引用
收藏
页码：S215 / S215
页数：1
相关论文
共 50 条
  • [21] A GLOBAL, MOLECULAR DISEASE CHARACTERIZATION INITIATIVE (MDCI) IN ONCOLOGY CLINICAL TRIALS
    Johnson, Melissa
    Sacher, Adrian
    Butler, Marcus
    Zarour, Hassane
    Weber, Jeffrey
    Garon, Edward
    Carbone, David
    Dhar, Arindam
    Messina, Cristina
    Patel, Roma
    Blouch, Kristin
    Hoos, Axel
    Martin, Anne-Marie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A423 - A423
  • [22] Analysis of inequality in nanomedicine using clinical trials and disease burden
    Woodson, Thomas
    Rodriguez, Victor
    NANOMEDICINE, 2019, 14 (13) : 1745 - 1757
  • [23] Minority Reporting and Representation in Cancer Clinical Trials: A Study of over 12,000 Clinical Trials
    Zaidi, Mohammad Y.
    Crowell, Kerri-Anne
    Hwang, E. Shelley
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S56 - S57
  • [24] Unnecessary exclusion: Eligibility criteria in gynecologic oncology interventional clinical trials impair access to trials
    Holtzman, Sharonne
    Letchinger, Riva
    Liu, Daniel
    Singh, Sunidhi
    Zamarin, Dmitriy
    Zakashansky, Konstantin
    Blank, Stephanie
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S449 - S449
  • [25] Principal investigator gender and trial success in gynecologic oncology clinical trials
    Barry, Danika
    Richardson, Michael
    Steinberg, Jecca
    Thirunavu, Vineeth
    Strom, Danielle
    Turner, Brandon
    Weeks, Brannon
    Laasiri, Nora
    Squires, Natalie
    Anderson, Jill
    Young, Anna Marie
    Andebrhan, Sarah
    Perry, Madeline
    Zhang, Naixin
    Holder, Kai
    Roque, Dario
    Salani, Ritu
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S281 - S282
  • [26] Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials
    Jorge, Soledad
    Masshoor, Shatreen
    Gray, Heidi J.
    Swisher, Elizabeth M.
    Doll, Kemi M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01): : 27 - +
  • [27] Clinical Trials in Gynecologic Oncology: Past, Present, and Future EDITORIAL COMMENT
    Annunziata, Christina M.
    Kohn, Elise C.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (05) : 278 - 279
  • [28] Disparities between high-impact clinical trials in oncology and disease burden.
    Pfanzelter, Nicklas
    Jeurkar, Neha
    Finkelman, Brian S.
    Mamtani, Ronac
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Economic analysis of multinational clinical trials in oncology
    Lejeune, Catherine
    Lueza, Beranger
    Bonastre, Julia
    BULLETIN DU CANCER, 2018, 105 (02) : 204 - 211
  • [30] Global analysis of clinical trials with probiotics
    Dronkers, Theresia M. G.
    Ouwehand, Arthur C.
    Rijkers, Ger T.
    HELIYON, 2020, 6 (07)
12345